The Veterans Affairs Department said it is firing four senior executives as officials move to crack down on wrongdoing following a nationwide scandal over long wait times for veterans seeking medical care, and falsified records covering up the delays.
Survey: Majority of CROs Exchange Regulated Clinical Trial Documents via Outdated, Hard-to-Track MethodsOctober 7, 2014 8:17 am | News | Comments
The vast majority of contract research organizations (CROs) surveyed lag clinical trial sponsors in how they exchange trial master file (TMF) documents, according to the Veeva 2014 Paperless TMF Survey: The State of CRO TMFs.
In a case underscoring the perils of caring for Ebola patients, a nurse in Spain who cared for an Ebola patient has come down with the disease — the first known transmission outside West Africa during the current epidemic.
West Pharmaceutical Services, Inc. has appointed Karen Flynn President of the company's Pharmaceutical Packaging Systems business. Flynn brings more than 28 years of experience to this role. Most recently, she held the position of President, Americas Region, Pharmaceutical Packaging Systems, where she was responsible for the Americas regional business segment, including both the manufacturing and commercial aspects of the business.
Officials at Texas Health Presbyterian Hospital said Monday that their patient, Thomas Eric Duncan, is in critical condition and being treated with brincidofovir, an oral medicine developed by Chimerix Inc.
These Laboratory Double Planetary Mixers (DPM's) are ideal for processing a wide range of applications including viscous pastes, putty-like materials, powder blends and granulations.
Teva has identified 14 pipeline projects for discontinuation or divestment. These projects amount to more than $150 million in R&D costs in 2015 and in excess of $200 million for each of 2016 and 2017. These cost savings will be directed, in part, to increasing resources in Teva's core therapeutic areas, while another part of which will support the company's efficiency objective.
Shares of Sunesis Pharmaceuticals tanked Monday, wiping out all their gains for 2014 and then some, after the drug developer said its treatment for an aggressive form of blood cancer missed its main goal in late-stage testing.
The enterovirus 68 has caused serious breathing problems in many children, and now is being eyed as possible factor in at least four deaths, and muscle weakness and paralysis in children in Colorado and perhaps other states. The CDC released a report on the Colorado cluster. The investigation continues and many questions remain unresolved.
As West Africa's Ebola outbreak continues to rage, some experts are coming to the conclusion that it may take large amounts of vaccines and maybe even drugs — all still experimental and in short supply — to bring the outbreak under control.
The specially equipped plane carrying Ashoka Mukpo landed at Eppley Airfield in Omaha at around 7:30 a.m. Monday. An ambulance was waiting to take him to the Nebraska Medical Center's specialized isolation unit, which is about a 20-minute ride from the airport.
AbbVie has announced that the FDA has approved the extension of the HUMIRA indication for moderately to severely active polyarticular juvenile idiopathic arthritis to reducing signs and symptoms in patients ages 2 and older. HUMIRA was approved in the United States in 2008 for polyarticular juvenile idiopathic arthritis in patients ages 4 and older.
Actavis has entered into a definitive merger agreement under which a subsidiary of Actavis will commence a tender offer to acquire all of the outstanding shares of Durata common stock for $23.00 per share in cash, or approximately $675 million.
Bristol-Myers Squibb and MD Anderson Cancer Center to Collaborate on Immuno-Oncology Focused Therapies for Leukemia and Hematologic MalignanciesOctober 6, 2014 8:10 am | News | Comments
Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo, Yervoy and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies.
Poor infrastructure, difficulties with equipment and torrential rains have slowed work for the U.S. military's initial response to the deadly Ebola outbreak in West Africa, but it is now ready to start erecting the main tent for a field hospital in Liberia.